BTA-9881
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
390.82
Molecular Formula
C21H15ClN4O2
Notes
Research use only, not for human use.
Receptor
RSV
CAS Number
1646857-24-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items